Catabasis Pharmaceuticals Profile

2.35
USD 0.02  0.84%
1.83Last Month High 3.03 
2.31Trading Day  High 2.41 

Acquisition by Jean George of 6500 shares of Catabasis Pharmaceuticals subject to Rule 16b-3

Catabasis Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by Jean George, the corporate stakeholder, on July 28, 2017. This event was filed by Catabasis Pharmaceuticals with SEC on 2017-07-28. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Catabasis Pharmaceuticals Summary

Catabasis Pharmaceuticals Inc (CATB) is traded on NASDAQ General Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 37 people. Catabasis Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 53.06 M. Catabasis Pharmaceuticals Inc has 22.48 M outstanding shares of which 837.33 K shares are currently shorted by private and institutional investors with about 4.95 trading days to cover. N/A currently holds about 29.37 M in cash with (28.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Check Catabasis Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Catabasis Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Catabasis Pharmaceuticals Against Markets

Current Ratings  

Catabasis Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
14 
Chance of
< 11% 
Catabasis Pharmaceuticals, Inc., a clinicalstage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameCatabasis Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMASSACHUSETTS, U.S.A
Business AddressCatabasis Pharmaceuticals, Inc.Cambridge, MA
ExchangeNASDAQ General Markets
CUSIP14875P107
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.catabasis.com
Contact Number617 349 1971
CurrencyUSD - US Dollar

Current Sentiment - CATB

Catabasis Pharmaceuticals Investor Sentiment
Most of Macroaxis users are currently bullish on Catabasis Pharmaceuticals Inc. What is your opinion about investing in Catabasis Pharmaceuticals Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
CATBSkip  Hide

Recommendations

Catabasis Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
8.25Buy4Odds
Catabasis Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Catabasis Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Catabasis Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.49March 1, 2017
Catabasis Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate